Clinical Trial

Response Profiles to High-concentration Capsaicin Desensitization in Patients with Peripheral Neuropathic Pain with or Without Allodynia: a Regional Multicenter Prospective Cohort

Study acronym: CAPSICAURA
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 13, 2025 (before its estimated June 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
Prospective multicenter cohort to determine patient profiles (associated factors, including allodynia) with a better response to pain desensitization by capsaicin delivered in the form of a high concentration patch (8%), in a population of patients with peripheral neuropathic pain and followed up in a pain consultation in the Auvergne Rhône Alpes region.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-04-05; most recent amendment 2025-02-11.
Status change: Not Yet Recruiting → Recruiting 2023-12-20
Trial Details
NCT Number NCT05817591
Lead Sponsor Centre Hospitalier Annecy Genevois
Conditions Peripheral Neuropathic Pain
Enrollment 400 participants
Start Date 2023-12-14
Primary Completion 2026-06-15 (estimated)
Study Completion 2026-06-15 (estimated)
Updated on ClinicalTrials.gov 2025-02-13